Stockreport

Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights

Nkarta, Inc.  (NKTX) 
PDF First patient dosed in each of Ntrust-1 and investigator-sponsored clinical trial (IST) of NKX019; enrollment ongoing in both studiesEnrollment in Ntrust-2 expected to i [Read more]